Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. | Hemasphere | 2023 | 37359190 | PubTator, text mining | PubMed |
| [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37357002 | PubTator, text mining | PubMed |
| Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques. | Cell Mol Life Sci | 2023 | 37353664 | PubTator, text mining | PubMed |
| Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment. | Cancers (Basel) | 2023 | 37345056 | PubTator, text mining | PubMed |
| T cells in health and disease. | Signal Transduct Target Ther | 2023 | 37332039 | PubTator, text mining | PubMed |
| Biomarkers as targets for CAR-T/NK cell therapy in AML. | Biomark Res | 2023 | 37330575 | PubTator, text mining | PubMed |
| Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory Primary Central Nervous System Lymphoma Patient. | Cancer Res Treat | 2023 | 37321275 | PubTator, text mining | PubMed |
| Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy. | Front Immunol | 2023 | 37313405 | PubTator, text mining | PubMed |
| CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2023 | 37311645 | PubTator, text mining | PubMed |
| Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents. | Cancer Immunol Immunother | 2023 | 37310433 | PubTator, text mining | PubMed |
| BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond. | Hemasphere | 2023 | 37304937 | PubTator, text mining | PubMed |
| Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma. | Oncol Res | 2023 | 37303739 | PubTator, text mining | PubMed |
| A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37297016 | PubTator, text mining | PubMed |
| Novel Investigational Agents and Pathways That May Influence the Future Management of Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37296920 | PubTator, text mining | PubMed |
| A Peptidisc-Based Survey of the Plasma Membrane Proteome of a Mammalian Cell. | Mol Cell Proteomics | 2023 | 37295717 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation profiling of CD4+ T lymphocytes identifies differentially methylated loci associated with adult primary refractory immune thrombocytopenia. | BMC Med Genomics | 2023 | 37291547 | PubTator, text mining | PubMed |
| A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. | J Cancer Res Clin Oncol | 2023 | 37291405 | PubTator, text mining | PubMed |
| B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation. | Cell Mol Immunol | 2023 | 37291237 | PubTator, text mining | PubMed |
| Genomic and transcriptomic characterization reveals B-cell hyperactivation and immune evasion in hepatitis B virus-associated diffuse large B-cell lymphoma. | Clin Transl Med | 2023 | 37288581 | PubTator, text mining | PubMed |
| IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities. | Front Immunol | 2023 | 37287982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=34